Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Latanoprost vs Tafluprost in POAG and OHT
NCT01162603Phase 4Completed
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Mar 2011
- Primary completion
- Apr 2012
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of tafluprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by ASST Spedali Civili di Brescia. Started Mar 2011; status: completed.
02
Drugs
tafluprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01162603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01162603.